Cargando…
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms
Though pancreatic cancer is uncommon, with an age-adjusted annual incidence of 12.9 cases per 100,000 person-years, it is considered a refractory cancer due to the mortality of 11.0 per 100,000 person-years. To efficiently identify patients with potentially surgically-curable pancreatic cancer, high...
Autor principal: | Honda, Kazufumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108558/ https://www.ncbi.nlm.nih.gov/pubmed/35491769 http://dx.doi.org/10.3233/CBM-210198 |
Ejemplares similares
-
Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer
por: Honda, Kazufumi, et al.
Publicado: (2016) -
Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer
por: Sato, Yu, et al.
Publicado: (2020) -
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
por: Honda, Kazufumi, et al.
Publicado: (2015) -
Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study
por: Kihara, Tomomi, et al.
Publicado: (2021) -
Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction
por: Hisamatsu, Takashi
Publicado: (2021)